Table 2 Prescribed antihypertensive medications in the GSR Korea cohort at baseline and 36 months
Baseline (N = 102) | 36 Months (N = 102) | P-value | |
|---|---|---|---|
Number of antihypertensive medication classes | 3.8 ± 1.0 | 3.8 ± 1.2 | 0.49 |
Angiotensin-converting enzyme inhibitors | 10 (9.8) | 8 (7.8) | 0.56 |
Angiotensin receptor blockers | 90 (88.2) | 91 (89.2) | 0.78 |
Calcium channel blockers | 90 (88.2) | 92 (90.2) | 0.56 |
Diuretics | 85 (83.3) | 74 (72.5) | 0.041 |
Spironolactone | 11 (10.8) | 14 (13.7) | 0.32 |
Beta blockers | 82 (80.4) | 76 (74.5) | 0.13 |
Alpha-adrenergic blocker | 14 (13.7) | 16 (15.7) | 0.56 |
Direct-acting vasodilators | 7 (6.9) | 11 (10.8) | 0.046 |
